Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 217, Issue 8, Pages -
Publisher
Rockefeller University Press
Online
2020-07-16
DOI
10.1084/jem.20191779
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- YAP and the Hippo pathway in cholangiocarcinoma
- (2019) Takaaki Sugihara et al. JOURNAL OF GASTROENTEROLOGY
- Tacrines for Alzheimer's disease therapy. III. The PyridoTacrines
- (2019) Cristóbal de los Ríos et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes
- (2019) Huiwen Song et al. Autophagy
- Dyrk3 loss activates the purine metabolism and promotes hepatocellular carcinoma progression
- (2019) Fei Ma et al. HEPATOLOGY
- p38γ is essential for cell cycle progression and liver tumorigenesis
- (2019) Antonia Tomás-Loba et al. NATURE
- CLK3 Is A Direct Target Of miR-144 And Contributes To Aggressive Progression In Hepatocellular Carcinoma
- (2019) Hua Li et al. OncoTargets and Therapy
- Crosstalk between lysine methylation and phosphorylation of ATG16L1 dictates the apoptosis of hypoxia/reoxygenation-induced cardiomyocytes
- (2018) Huiwen Song et al. Autophagy
- Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells
- (2018) Elizabeth Bowler et al. BMC CANCER
- Harmine, a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor induces caspase-mediated apoptosis in neuroblastoma
- (2018) Katie L. Uhl et al. Cancer Cell International
- Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1
- (2018) Yuekun Zhu et al. CELL DEATH AND DIFFERENTIATION
- A CLK3-HMGA2 Alternative Splicing Axis Impacts Human Hematopoietic Stem Cell Molecular Identity throughout Development
- (2018) Marcella Cesana et al. Cell Stem Cell
- Targeting posttranslational modifications of RIOK1 inhibits the progression of colorectal and gastric cancers
- (2018) Xuehui Hong et al. eLife
- Novel tacrine platinum(II) complexes display high anticancer activity via inhibition of telomerase activity, dysfunction of mitochondria, and activation of the p53 signaling pathway
- (2018) Qi-Pin Qin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Potential Mechanisms Connecting Purine Metabolism and Cancer Therapy
- (2018) Jie Yin et al. Frontiers in Immunology
- Type VI collagen promotes lung epithelial cell spreading and wound-closure
- (2018) Jared A. Mereness et al. PLoS One
- Classical VEGF, Notch and Ang signalling in cancer angiogenesis, alternative approaches and future directions
- (2017) Nunzia Caporarello et al. Molecular Medicine Reports
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- DYRK1A inhibition as potential treatment for Alzheimer’s disease
- (2016) Silvia Stotani et al. Future Medicinal Chemistry
- Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination
- (2016) Xiaoguang Fang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/β-catenin activation
- (2016) Chao Qu et al. JOURNAL OF HEPATOLOGY
- An improved smaller biotin ligase for BioID proximity labeling
- (2016) Dae In Kim et al. MOLECULAR BIOLOGY OF THE CELL
- mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle
- (2016) I. Ben-Sahra et al. SCIENCE
- Molecular genetics and targeted therapeutics in biliary tract carcinoma
- (2016) Eric I Marks WORLD JOURNAL OF GASTROENTEROLOGY
- The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets
- (2016) Dawn Q. Chong et al. Oncotarget
- Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis
- (2014) Ruipeng Song et al. HEPATOLOGY
- Hydroxybenzothiophene Ketones Are Efficient Pre-mRNA Splicing Modulators Due to Dual Inhibition of Dyrk1A and Clk1/4
- (2014) Christian Schmitt et al. ACS Medicinal Chemistry Letters
- PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis
- (2013) Xuehui Hong et al. GUT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now